Phase 1 Study of Shattuck Labs (SL)-172154 in Subjects With MDS or AML

NCT05275439 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

106

Enrollment

INDUSTRY

Sponsor class

Stopped Development discontinued

Conditions

Acute Myeloid Leukemia
Myelodysplastic Syndromes

Interventions

DRUG: SL-172154
DRUG: Azacitidine (AZA)
DRUG: Venetoclax

Sponsor

Shattuck Labs, Inc.